SCHEMBL82865

SCHEMBL82865

CC(C(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C)C1CCCC1

nearest known ligand 0.83

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 8/20 0.83
PGR P06401 4/20 0.72
NR3C1 P04150 4/20 0.72
HIF1A Q16665 7/20 0.71
KMT2A Q03164 2/20 0.71
CYP2C19 P33261 2/20 0.64
HSD17B10 Q99714 2/20 0.64
CYP3A4 P08684 2/20 0.64
SERPINA6 P08185 2/20 0.64
SHBG P04278 1/20 0.64
MAPT P10636 1/20 0.64
NFKB1 P19838 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
AR P10275 3/20 0.63
CHRM1 P11229 2/20 0.63
LMNA P02545 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14935798 0.91 NR3C2 (1.00) NR3C2PGRNR3C1HIF1AKMT2A
SCHEMBL14935799 0.91 NR3C2 (1.00) NR3C2PGRNR3C1HIF1AKMT2A
SCHEMBL1028308 0.90 NR3C2 (0.89) NR3C2PGRNR3C1HIF1AKMT2A
SCHEMBL17977250 0.90 NR3C2 (0.87) NR3C2PGRNR3C1HIF1AKMT2A
SCHEMBL10597293 0.89 NR3C2 (0.86) NR3C2PGRNR3C1HIF1AKMT2A
SCHEMBL28495549 0.88 NR3C2 (0.82) NR3C2PGRNR3C1HIF1AKMT2A
SCHEMBL11293782 0.88 NR3C2 (0.84) NR3C2PGRNR3C1HIF1AKMT2A
SCHEMBL28399203 0.87 NR3C2 (0.83) NR3C2PGRNR3C1HIF1AKMT2A
SCHEMBL17977247 0.87 NR3C2 (0.83) NR3C2PGRNR3C1HIF1AKMT2A
SCHEMBL14935895 0.87 NR3C2 (0.79) NR3C2PGRNR3C1HIF1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2219 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022094174-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESOPHAGEAL CONDITIONS CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2022-05-05 WO claimed
WO-2020068665-A1 USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN FABIUS BIOTECHNOLOGY (US) 2020-04-02 WO claimed
US-20180133149-A1 DRUG-DELIVERING COMPOSITE STRUCTURES ZILBERMAN, MEITAL (IL) 2018-05-17 US claimed
US-9101662-B2 Compositions with modulating agents FOAMIX PHARMACEUTICALS LTD. (IL) 2015-08-11 US claimed
US-9072667-B2 Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses FOAMIX PHARMACEUTICALS LTD. (IL) 2015-07-07 US claimed
US-8795693-B2 Compositions with modulating agents FOAMIX LTD. (IL) 2014-08-05 US claimed
US-8784780-B2 High oil-content emollient aerosol foam compositions PRECISION DERMATOLOGY, INC. (US) 2014-07-22 US claimed
US-8636982-B2 Wax foamable vehicle and pharmaceutical compositions thereof FOAMIX LTD. (IL) 2014-01-28 US claimed
WO-2013138744-A1 COMPOSITIONS FOR THE TREATMENT OF SKIN DISORDERS M. ALPHABET 1, LLC (US) 2013-09-19 WO claimed
US-20130164225-A1 FOAMABLE VEHICLE AND PHARMACEUTICAL COMPOSITIONS THEREOF FOAMIX LTD. (IL) 2013-06-27 US claimed
EP-0614354-B1 USE OF SALICYLIC ACID FOR REGULATING SKIN ATROPHY RICHARDSON VICKS INC (US) 2001-01-17 EP claimed
US-5804572-A APPLYING SALICYLIC ACID, AND AN ANTIINFLAMMTORY AGENT WITH A CARRIER THE PROCTER & GAMBLE COMPANY (US) 1998-09-08 US claimed
US-5756487-A Use of salicyclic acid for regulating skin wrinkles and or skin atrophy RICHARDSON-VICKS INC. (US) 1998-05-26 US claimed
US-5605894-A A MIXTURE OF SALICYLIC ACID, A SUNSCEEN, ANTIINFLAMMATORY AGENT, VITAMIN, ANTIOXIDANT, CHELATOR, RETINOID, A BENZUFURAN, AN N-ACETYL-L-CYSTEINE AND A SKIN PROTECTANT; NONTOXIC RICHARDSON-VICKS INC. (US) 1997-02-25 US claimed
US-5597813-A COMPOSITION INCLUDES AN ANTIINFLAMMATORY AGENT RICHARDSON-VICKS INC. (US) 1997-01-28 US claimed
EP-0614353-A1 COMPOSITIONS FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY RICHARDSON-VICKS, INC. (US) 1994-09-14 EP claimed
EP-0614354-A1 USE OF SALICYLIC ACID FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY RICHARDSON-VICKS, INC. (US) 1994-09-14 EP claimed
WO-1993010755-A1 COMPOSITIONS FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY RICHARDSON-VICKS, INC. (US) 1993-06-10 WO claimed
WO-1993010756-A1 USE OF SALICYLIC ACID FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY RICHARDSON-VICKS, INC. (US) 1993-06-10 WO claimed
US-4304765-A Ocular insert housing steroid in two different therapeutic forms ALZA CORPORATION (US) 1981-12-08 US claimed